Biogen Inc. buy Cantor Fitzgerald
Start price
20.12.23
/
50%
€230.20
Target price
20.12.24
€283.73
Performance (%)
-39.07%
End price
21.12.24
€140.25
Summary
This prediction ended on 21.12.24 with a price of €140.25. The BUY prediction by Cantor_Fitzgerald for Biogen Inc. performed very badly with a performance of -39.07%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 0.889% | 0.889% | 24.991% |
| iShares Core DAX® | -2.526% | -5.194% | 4.911% |
| iShares Nasdaq 100 | -0.032% | 1.561% | 21.789% |
| iShares Nikkei 225® | -4.202% | -7.550% | 31.128% |
| iShares S&P 500 | -0.802% | 0.160% | 15.782% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $311.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten